GABA

GABA(A) receptor benzodiazepine drug history remifentanil rhesus monkey self-administration

Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 Aug 2020
Historique:
received: 17 12 2019
revised: 12 05 2020
accepted: 13 05 2020
medline: 1 6 2020
pubmed: 1 6 2020
entrez: 1 6 2020
Statut: ppublish

Résumé

Opioid-use disorder is associated with a high degree of co-abuse with benzodiazepines. While the mechanisms underlying the co-abuse of opioids and benzodiazepines remain unknown, α1 subunit-containing GABA The reinforcing effects of L-838,417 (partial intrinsic efficacy at α2, α3, and α5 subunit-containing GABA Neither the partial modulator nor the α1-sparing compound were self-administered above vehicle levels. The full modulators triazolam and lorazepam were self-administered significantly above vehicle levels, albeit at lower levels than remifentanil. Our findings suggest that relatively high efficacy at one or more GABA

Sections du résumé

BACKGROUND BACKGROUND
Opioid-use disorder is associated with a high degree of co-abuse with benzodiazepines. While the mechanisms underlying the co-abuse of opioids and benzodiazepines remain unknown, α1 subunit-containing GABA
METHODS METHODS
The reinforcing effects of L-838,417 (partial intrinsic efficacy at α2, α3, and α5 subunit-containing GABA
RESULTS RESULTS
Neither the partial modulator nor the α1-sparing compound were self-administered above vehicle levels. The full modulators triazolam and lorazepam were self-administered significantly above vehicle levels, albeit at lower levels than remifentanil.
CONCLUSIONS CONCLUSIONS
Our findings suggest that relatively high efficacy at one or more GABA

Identifiants

pubmed: 32474260
pii: S0376-8716(20)30241-6
doi: 10.1016/j.drugalcdep.2020.108076
pmc: PMC7371532
mid: NIHMS1598394
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108076

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA011792
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA043204
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Lais F Berro (LF)

Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N State St, Jackson, MS, 39216, USA. Electronic address: lberro@umc.edu.

James K Rowlett (JK)

Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N State St, Jackson, MS, 39216, USA.

Classifications MeSH